Back to search

Article

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

2023-07-11

Abstract excerpt

<h4>ABSTRACT</h4> Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is aberrantly expressed in a small subset of primary tumors. Here, we report that DUX4 expression is a common feature of metastatic tumors, with ∼...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
211b159e-a3cd-591c-a338-7432808d33f5
DOI
10.1101/2023.07.10.548412
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancersDOI 10.1101/2023.07.10.548412
Select a neighboring publication to make it the new centre.